Oral health-related quality of life before and after crown therapy in young patients with amelogenesis imperfecta by unknown
RESEARCH Open Access
Oral health-related quality of life before
and after crown therapy in young patients
with amelogenesis imperfecta
Gunilla Pousette Lundgren1,2*, Agneta Karsten3 and Göran Dahllöf1
Abstract
Background: Amelogenesis imperfecta (AI) is a rare, genetically determined defect in enamel mineralization
associated with poor esthetics and dental sensitivity. Because the condition is associated with negative social
outcomes, this study evaluated oral health-related quality of life (OHRQoL), dental fear, and dental beliefs before
and after early prosthetic crown therapy for AI during adolescence.
Methods: The study included 69 patients with AI, aged 6–25 yr: 33 males and 36 females (mean age 14.5 ± 4.3);
healthy controls (n = 80), patients with cleft lip and palate (CLP; n = 30), and patients with molar incisor
hypomineralization (MIH; n = 39). All matched in age and gender, and all but the CLP group insocioeconomic area.
Patients completed three questionnaires measuring OHRQoL (OHIP-14), dental fear (CFSS-DS), and dental beliefs
(DBS-R). Twenty-six patients with severe AI between ages 9 and 22 yr received crown therapy and completed the
questionnaires twice: before and after therapy.
Results: OHIP-14 scores were significantly higher among patients with AI (7.0 ± 6.7), MIH (6.8 ± 7.6) and CLP (13.6
± 12.1) than healthy controls (1.4 ± 2.4) (p < 0.001). After crown therapy, quality of life problems in the 26 patients
with severe AI decreased significantly, from 7.8 ± 6.1 to 3.0 ± 4.8 (p < 0.001). Early prosthetic therapy did not
increase dental fear or negative attitudes toward dental treatment.
Conclusions: OHRQoL increased after early crown therapy in patients with severe AI. Therapy did not increase
dental fear or negative attitudes toward dental treatment.
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Background
Amelogenesis imperfecta (AI) is a rare, genetically deter-
mined defect in enamel mineralization with a prevalence
between 1:14,000 and 1:700 [1, 2]. Disturbances in the
enamel matrix phase result in quantitative defects, as in
the hypoplastic form of AI with small, thin teeth, teeth
with pits and grooves, or areas without enamel (Fig. 1a
before crown therapy, 1 B after crown therapy). Distur-
bances during the enamel mineralization phase result in
qualitative defects, as in the hypomineralized form or
hypomaturized form of AI (Fig. 1c before crown therapy,
1 D after crown therapy) [3, 4]. The teeth of patients
with AI are prone to disintegration, as well as to hyper-
sensitivity, and patients with AI have more frequent den-
tal appointments and restorations of poorer quality
compared to other patients [5]. Current guidelines for
restorative treatment suggest covering the surface with
direct composite or composite veneers until adulthood
and recommend stainless steel crowns for first perman-
ent molars as a temporary solution in childhood and
adolescence [6, 7]. Patients with AI often ask for a more
permanent treatment at an earlier age [8]. A recent re-
port shows excellent 2-yr survival of porcelain crowns in
adolescents and young adults with AI [9].
Oral health-related quality of life (OHRQoL) is the re-
sult of an interaction between oral health conditions,
and social and contextual factors [10]. AI has major
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psychological and social implications for OHRQoL.
Adult patients with AI report significantly lower OHR-
QoL compared to controls [11]. Parekh et al. [12] report
that children and adolescents with AI have concerns re-
garding esthetics and function as well as a high level of
concern about comments by other people.
Underlying pathological or psychological conditions
can also affect patient attitudes toward dentists and den-
tal health care [13]. Young patients with stable favorable
dental beliefs had better clinical status and better self-
rated oral health than those with less stable beliefs. Fac-
tors such as previous experience of pain and low general
well-being affect attitudes toward dentistry [14].
The aim of this investigation was to study OHRQoL,
dental fear, and anxiety, as well as attitudes towards den-
tistry in a group of adolescents and young adults with
AI. The hypotheses were that adolescents and young
adults with AI have lower OHRQoL, higher levels of
dental anxiety, and more negative attitudes toward den-
tal care compared with controls; and that OHRQoL in
these patients improves after crown therapy.
Methods
This study followed the Declaration of Helsinki guide-
lines and was approved by the Regional Ethics Review
Board in Uppsala (Daybook number 2008/108).
The study recruited patients from 22 Public Dental
Service (PDS) clinics in Dalarna County, Sweden, mainly
from rural areas and small towns. PDS clinics in Sweden
provide free dental care for children from 3 to 19 years
of age and also treat adult patients who pay for their
own care. Adults with AI have access to subsidized pros-
thetic therapy. Study participants were patients with AI
who had been referred to the Department of Pediatric
Dentistry, PDS in Falun. To be included, patients needed
a clinically verified AI diagnosis, confirmed by anamnes-
tic familial history and/or histological examination. We
invited 80 patients with AI to participate in this study.
We included three control groups in this study. The
first control group was a healthy control group of chil-
dren with no dental or medical disorders who regularly
attended PDS clinics in Dalarna County. The second
group was children with molar incisor hypomineraliza-
tion (MIH); these children exhibit similar problems to
patients with AI, including increased sensitivity, frequent
dental treatments, and a higher level of dental fear and
anxiety [15]. The definition of MIH used in this study
was: hypomineralization of systemic origin of one to four
first permanent molars that is frequently associated with
affected incisors [16]. The third control group comprised
patients with cleft lip and palate (CLP); like patients with
AI, they exhibit disturbances in dental development, fre-
quent dental treatments, esthetic challenges, and persist-
ing sequelae after completion of therapy. They also
report a lower OHRQoL [17, 18].
To form the control groups, we sent invitations to 80
healthy controls and 80 patients with MIH from PDS
clinics in Dalarna, and 80 patients with CLP from the
Stockholm Craniofacial Center. The three control
groups were matched for age and gender to the patients
with AI. The healthy controls and the patients with MIH
came from the same socioeconomic area as the patients
with AI. Patients with AI and healthy controls answered
the questionnaires concerning regular dental appoint-
ments. All study participants were recruited between
December 2008 and February 2013. The parents were
asked to assist their children if below nine years of age,
explaining the questionnaires and asked to record their
children’s experiences. We sent questionnaires to the
MIH and CLP groups by land mail in November 2012
and included a self-addressed, stamped envelope. These
groups received one reminder 4 months later.
Questionnaires
We used the 14-item oral health impact profile (OHIP-
14) [19], a short version of the OHIP-49 [20], to study
Fig. 1 Hypoplastic form of AI before a and after b crown therapy and hypomineralized/ hypomaturized form of AI before c and after d crown therapy
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OHRQoL. The Swedish version has been tested for reli-
ability and validity [21]. The OHIP-14 is preferable when
describing OHRQoL on a population basis and attempt-
ing to detect changes over time [22]. It focuses on four
dimensions of impact: orofacial pain, oral function, oro-
facial appearance, and psychosocial impact [23]. The
OHIP scales use the five-point Likert scale (never = 0,
seldom = 1, sometimes = 2, fairly often = 3, and very
often = 4) for responses. We calculated the mean scores
for each item and compared them within the groups.
Adding the scores for the 14 items gave a total OHIP-14
score ranging from 0 to 56, with higher scores indicating
poorer OHRQoL. We excluded subjects with more than
five missing OHIP responses from the analyses; if there
were five or fewer missing responses, the missing values
received the subject’s median response score [23].
The Children’s Fear Survey Schedule – Dental Sub-
scale (CFSS-DS) measures dental fear and anxiety [24].
This psychometric scale consists of 15 items, where each
item can give a score from 1 (not afraid) to 5 (very
afraid). Thus, possible total scores range from 15 to 75.
Calculations suggest a population-based mean value on
the CFSS-DS of 23 (SD 8) for 9–11-year-old Swedish
children [25]. A score ≥38 indicates dental fear [26]. For
the CFSS-DS questionnaires with fewer than five items
missing, we replaced missing items using specific-item
means [27].
The dental belief survey (DBS-R) examines interper-
sonal processes and relationships between the patient and
the dental care provider [28]. It includes 28 items, cover-
ing three dimensions of the interpersonal relationship as
conceived by the patient: the ethical dimension, communi-
cation, and control. Each item has five score levels from 1
to 5 with 1 indicating no concern and 5 indicating greatest
concern. The outcome of the DBS-R is a sum of scores ran-
ging between 28 (highly positive) and 140 (highly negative)
[29]. A total score > 42 is the cut-off indicating negative at-
titudes towards dental care [30]. Patients were excluded if
more than 20 % of their items contained missing data [28].
We recorded tooth sensitivity for the entire dentition in
patients with AI using a visual analogue scale (VAS), con-
sidering a score below 3 to indicate no or low pain [31]
Measurements before and after early crown therapy in
patients with AI
The AI group contained 26 patients diagnosed with se-
vere AI who needed crown therapy. They answered their
questionnaires before treatment at their dental examin-
ation. After treatment with porcelain crowns (Fig. 1b, d)
the patients answered the questionnaires again at the
two-year follow-up examination. We calculated change
in OHIP-14 score and sub-dimension scores by subtract-
ing the scores after treatment from the baseline scores,
so positive values indicated improvement and negative
scores worsening of OHRQoL.
To estimate the minimally important difference, we
used both anchor- and distribution-based methods. We
defined no or low tooth sensitivity (VAS score < 3) after
crown therapy as a positive treatment outcome and used
it as an anchor. We then estimated effect size (ES) using
Cohen’s techniques as the distribution method [32, 33].
Statistical analyses
The Mann–Whitney U-test examined differences be-
tween groups. Logistic regression analyses evaluated the
influence of age, gender, visits per year, severity of AI,
and VAS score on the dependent variables of OHRQoL,
dental fear, and dental beliefs. Cronbach’s alpha calcu-
lated the internal consistency reliability of the OHIP-14
scale. Treatment effects of crown therapy in patients
with severe AI were compared with the Wilcoxon signed
rank test, and ES calculated with Cohen’s d based on
pooled standard deviations. We considered a treatment
effect to be trivial if ES was < 0.20, small if 0.2 ≤ ES < 0.5,
moderate if 0.5 ≤ ES <0.8, and large if 0.8 ≤ ES.
All analyses were done using the Statistical Package
for the Social Sciences (SPSS, ver. 22; Chicago, IL, USA).
Results
We invited 80 patients with AI to participate in this
study and excluded 7 of these because we could not rule
out alternative diagnoses. Another 4 did not answer the
questionnaires. The remaining 69 patients with AI in-
cluded 33 males and 36 females (aged 6–25 yr, mean
14.5 ± 4.3). Of these, 33 had hypoplastic type-AI and 36,
hypomineralized/hypomatured-type AI. The healthy
controls from PDS clinics included 80 patients, 36 boys
and 44 girls (aged 6–25 yr, mean 14.7 ± 4.4). Thirty-nine
patients with MIH (17 boys and 22 girls aged 8–23 yr,
mean 14.7 ± 4.1), and 30 patients with CLP (12 boys and
18 girls aged 6–25 yr, mean 14.8 ± 4.8) returned the
questionnaires.
Among the patients with AI, 26 (aged 9–22 yr, mean
16.1 ± 3.1) received a diagnosis of severe AI and needed
restorative treatment (Fig. 2). The patients received be-
tween 1 and 24 crowns each (mean 11 ± 6) (Fig. 3),
resulting in 329 crowns total. Four patients receiving
crown therapy moved out of the country and did not
complete the questionnaires after therapy.
Quality of life
The total OHIP-14 score was significantly higher among
patients with AI (7.0 ± 6.7), MIH (6.8 ± 7.6), and CLP
(13.6 ± 12.1) compared to the healthy control group (1.4
± 2.4). The CLP group scored significantly higher than
the AI and MIH groups (Table 1). Within the different
OHIP-14 domains, adolescents in the AI group scored
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significantly higher on all sub-dimensions of the ques-
tionnaire compared to the control group (Table 2). Items
with the highest score among AI patients were orofacial
appearance and orofacial pain. Most problems reported
in the control group were in orofacial pain. In the MIH
group, orofacial pain and orofacial appearance had the
highest scores. Patients with CLP scored high on all four
dimensions with orofacial appearance and highest on
oral function. Internal reliability (Crohnbach’s α) of the
OHIP-14 items in this population aged between 6 and
25 years was 0.886. The individual items varied between
0.869 and 0.892.
Change in OHRQoL after crown therapy in AI patients
Two years after crown therapy, OHRQoL improved sig-
nificantly, total scores decreased from 8.8 ± 5.9 to 2.0 ±
2.5 (p< 0.001), and the total mean score for all items de-
creased from 0.6 ± 0.4 to 0.2 ± 0.2 (p< 0.001). Fig. 4
shows the distribution of improvement in OHIP-14
scores after crown therapy. No patient had an increase
Fig. 2 Age of patients with AI in crown group and no crown group
Fig. 3 Number of crowns made in each patient and type of AI
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Table 1 Scores from the Oral Health Impact Profile (OHIP-14), the Children’s Fear Survey Schedule – Dental Subscale (CFSS-DS), and
the Dental Belief Survey (DBS-R) in the amelogenesis imperfecta (AI) study group and the three control groups: healthy controls
(CTR), molar incisor hypomineralization (MIH), and cleft lip and palate (CLP)
Variables AI all CTR MIH CLP Significancea
(n = 69) (n = 80) (n = 39) (n = 30)
(x ± sd) (x ± sd) (x ± sd) (x ± sd)
OHIP-14 total sum 7.0 ± 6.7 1.4 ± 2.4 6.8 ± 7.6 13.6 ± 12.1 AI-CTR p < 0.001;
AI-CLP p = 0.034;
MIH-CTR p < 0.001;
CLP-CTR p < 0.001;
MIH-CLP p = 0.037
OHIP-14 mean 3.5 ± 3.4 0.7 ± 1.2 3.5 ± 3.8 7.4 ± 7.6 AI-CTR p < 0.001;
AI-CLP p = 0.033;
MIH-CTR p < 0.001;
CLP-CTR p < 0.001;
MIH-CLP p = 0.029
CFSS-DS 18.8 ± 5.7 18.8 ± 4.6 24.0 ± 8.9 22.1 ± 8.9 AI-MIH p = 0.001;
AI-CLP p = 0.038;
MIH-CTR p < 0.001;
CLP-CTR p = 0.026
DBS-R 32.4 ± 6.4 32.1 ± 5.8 43.3 ± 20.1 38.6 ± 17.2 AI-MIH p = 0.002;
AI-CLP p = 0.08;
MIH-CTR p = 0.002;
CLP-CTR p = 0.033
aMann Whitney U-test
Table 2 Subdimenisons of the Oral Health Impact Profile (OHIP-14) in the amelogenesis imperfecta (AI) study group and the three
control groups: healthy controls (CTR), molar incisor hypomineralization (MIH), and cleft lip and palate (CLP)
OHIP-14 AI total CTR MIH CLP Significancea
(n = 69) (n = 80) (n = 39) (n = 30)
(x ± sd) (x ± sd) (x ± sd) (x ± sd)
Oral function 0.29 ± 0.38 0.12 ± 0.24 0.51 ± 0.66 1.14 ± 1.09 AI-CTR p = 0.001;
AI-CLP p < 0.001;
CTR-MIH p < 0.001;
CTR-CLP p < 0.001;
MIH-CLP p = 0.013
Orofacial pain 0.61 ± 0.83 0.22 ± 0.48 0.84 ± 1.01 1.13 ± 1.12 AI-CTR p = 0.002;
CTR-MIH p < 0.001;
CTR -CLP p < 0.001
Orofacial appearance 1.15 ± 1.31 0.17 ± 0.50 0.70 ± 1.05 1.38 ± 1.31 AI-CTR p < 0.001;
CTR-MIH p = 0.001;
CTR-CLP p < 0.001
Psychosocial impact 0.54 ± 0.63 0.06 ± 0.18 0.39 ± 0.52 0.93 ± 1.11 AI-CTR p < 0.001;
AI-CLP p = 0.002;
CTR-MIH p < 0.001;
CTR -CLP p < 0.001
aMann–Whitney U-test
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in total OHIP-14 score after therapy. We found signifi-
cant improvements in two of four OHIP-14 domains:
psychosocial impact and orofacial impact (Table 3).
The study recorded sensitivity of teeth before and
after crown therapy using a VAS scale. Before therapy,
19 of 26 patients (73 %) reported a VAS score > 3
while after crown therapy only three patients (12 %)
reported a score > 3.
We calculated the minimally important difference in
two ways. The anchor-based method used sensitivity
(VAS score < 3) as criteria for an important positive
treatment effect. The 19 patients who had a VAS score <
3 after crown therapy had a mean improvement of five
points in their OHIP-14 scores. Nine of 26 patients had
a decrease of ≥ 5 points in their total OHIP-14 score. For
the distribution-based method, estimated ES (Cohen’s d)
for the total OHIP-14 score was 1.24 (95 % CI 0.62-1.85)
(Table 3).
Dental fear
The CFSS-DS score in AI patients, 18.8 ± 5.7, was signifi-
cantly lower than in the MIH group (24.0 ± 8.9, p = 0.001)
and in the CLP group (22.1 ± 8.9, p = 0.038). Differences
in CFSS-DS scores between the AI group and the control
group (18.8 ± 4.6, Table 1) were non-significant. Among
the various items, “injection,” “the dentist drilling,” and
“choking” were the most fearful situations for all groups.
Total CFSS-DS scores in patients with AI did not differ
before and after crown therapy.
Dental beliefs
Patients with AI scored 32.4 ± 6.4 on the DBS-R, not sig-
nificantly different from the controls’ 32.1 ± 5.8. Three
patients had scores ≥ 42. The highest scores of negative
expectations appeared in the MIH group 43.3 ± 20.1,
significantly higher than AI patients (p < 0.002) and
controls (p < 0.002), with 15 patients scoring ≥ 42. Re-
garding specific items, all groups mentioned lack of
control as their most troublesome worry. “When I am
in the chair, I don’t feel like I can stop the appoint-
ment for a rest if I feel the need” was ranked first in
the MIH and CLP groups, second in the AI group,
and third in the control group.
The total DBS-R score was 31.7 ± 3.9 in the severe AI
group before therapy and did not change after therapy
(31.2 ± 4.4). In this group, ranking of the item “I am con-
cerned that the dentist is not really looking out for my
best interests” fell from the top concern before therapy
to twelfth after therapy.
Discussion
The results of this study showed that adolescents and
young adults with AI reported a significantly lower
OHRQoL compared to healthy controls and that defini-
tive therapy with porcelain crowns at this age signifi-
cantly improved OHRQoL. We have also shown that
this improvement is clinically significant.
Many dental conditions have psychological and so-
cial implications; thus, patient reported outcomes
should supplement specific dental outcome measures
[34]. In this study, patient age varied between 6 and
25 years. Although the OHIP-14 hasn’t been validated
in younger children [35], we decided to use this scale,
because the majority were teenagers and young
adults. And although the 49 items of the OHIP-49
Fig. 4 The distribution of improvement in OHIP-14 scores after
crown therapy
Table 3 Sub-dimension scores of the Oral Health Impact Profile (OHIP-14) in 26 adolescents and young adults with amelogenesis
imperfecta before and 2 yr after crown therapy
OHIP-14 dimensions Sub-score Significance (p*) Effect size (95 % CI)
Before therapy 2 yr after therapy
(x ± sd) (x ± sd)
Oral function 0.25 ± 0.26 0.18 ± 0.22 0.2180 0.29 (−0.26 – 0.84)
Orofacial pain 0.69 ± 0.84 0.48 ± 0.65 0.2270 0.28 (−0.26 – 0.82)
Orofacial appearance 1.31 ± 1.32 0.28 ± 0.74 0.0014 0.96 (0.26 – 1.66)
Psychosocial impact 0.64 ± 0.64 0.10 ± 0.24 0.0002 1.06 (0.44 – 1.67)
Total score OHIP-14 8.08 ± 5.93 2.04 ± 2.49 0.0001 1.24 (0.62 – 1.85)
* =Wilcoxon signed rank test
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are reduced to 14 in the OHIP-14, it shows good
statistical properties and validity [19].
The determinants of quality of life include biological
and physiological factors, symptom and functional sta-
tus, and the individual’s general health perceptions [36].
For adolescents and young adults, appearance is import-
ant. Physical growth combined with cultural pressure to
conform to beauty ideals often results in teenagers be-
coming preoccupied with their own and others’ appear-
ance [37].
AI has consequences for individuals living with the
condition. The negative esthetic experience from tooth
discoloration and reduced crown size in patients with AI
leads to higher levels of social avoidance and distress
than subjects without the condition [38]. Patients diag-
nosed with AI are more often single compared to con-
trols and have fewer children [39].
In this study, children with AI reported a significantly
lower OHRQoL compared to healthy controls. This
agrees with two previous studies of adult patients with
AI [11, 39]. The mean total OHIP-14 score in the study
of AI patients with a mean age of 36 years was 25 [39],
compared to a mean score of 7 in our group of patients
with a mean age of 15. This can be explained by the
many years of living with an esthetically suboptimal den-
tition, increased sensitivity, and frequent dental visits for
replacement of restorations [5].
Adolescents and young adults with CLP had a signifi-
cantly poorer OHRQoL compared to controls, patients
with AI, and patients with MIH. A previous study also
reported poor OHRQoL in teenagers with CLP [40]. The
Child Oral Health Impact Profile score was negatively
correlated with depressive symptoms and positively cor-
related with factors such as self-concept and mastery.
The presence of appearance-altering conditions does not
necessarily result in poor psychological well-being be-
cause social, environmental, and psychological factors
may mediate coping and adjustment in patients.
It is important to identify patients or groups of pa-
tients at the greatest risk of suffering from a low OHR-
QoL due to poor oral health (or, as in this case, due to
congenital dental aberrations) independently of clinical
oral health factors. Reports even suggest that children of
mothers who report poor OHRQoL are at greater risk of
a low OHRQoL later in life [41]. The low scores on
OHRQoL among AI patients is a consequence of the
current treatment paradigm. The change we observed
after treatment strongly suggests that this paradigm
should be altered to include early prosthetic therapy.
Minimally important difference is an important con-
cept when interpreting results from longitudinal studies
of the effects of dental treatment on OHRQoL. It is usu-
ally defined as the smallest difference in score that pa-
tients perceive as beneficial, and which would mandate a
change in patient management in the absence of
troublesome side effects and costs [42]. The results
clearly show a significant positive effect on OHRQoL for
crown therapy in patients with AI. The OHIP-14 score
reduced significantly compared to controls, and none of
the patients reported a worsening score. We have previ-
ously shown a significant reduction in tooth sensitivity
after crown therapy in patients with AI [9]. A reduction
in VAS pain score below 3, which indicates no pain or
low pain that doesn’t require analgesics [43], was our
standard for determining a clinically important differ-
ence in OHRQoL. We found that the OHIP-14 scores of
patients who reported a VAS pain score below 3 de-
creased by 5 points after therapy and that nine patients
of 26 (35 %) had a ≥ 5-point reduction. This is similar to
the minimally important difference for OHIP-14 re-
ported in a study of adult patients receiving periodontal
therapy, which reported a 5-point decrease for a third of
the patients [32]. ES calculations are useful when the
measurements have no intrinsic meaning (points on a
scale) and are independent of sample size [44]. In this
study, the ES (Cohen’s d) for within-group comparisons
was 1.24, which is a very large treatment effect [45]. Par-
ental reports on the Early Childhood Oral Health Impact
Scale after treatment under general anesthesia for early
childhood caries yielded an even larger ES of 2.1 [46].
For comparison, Mashoto et al. [47] reported an ES of
0.2 after atraumatic restorative treatment in Tanzanian
schoolchildren using the Child-Oral Impacts on Daily
Performance instrument. None of the patients with AI
who received crown therapy reported a worsening OHR-
QoL, which is an important aspect of their responsive-
ness to treatment that adds strength to the results [48].
Both patients with MIH and patients with CLP showed
higher levels of dental fear. For children with CLP, ex-
tensive medical treatment naturally contributes to this.
The extensive therapy in the severe AI group, however,
did not cause a worsening of dental fear. This might be
due to a positive treatment outcome, comparable the in-
creased satisfaction after surgery that patients with CLP
experience, resulting in more positive OHRQoL scores
[17]. Skaret et al. found a tendency toward increased
dental fear in 20-year-old dental patients having more
than one medical experience [14]. The patients most se-
verely affected with AI received treatment at the
pediatric dentistry clinic while almost all patients with
MIH were treated in the PDS clinics. For the patients
with AI, treatment approaches sought to introduce treat-
ment in an individualized way and to use analgesics and
nitrous oxygen to minimize stress and procedural pain.
After receiving their first crowns, patients were asked to
decide whether to stop or go on with more therapy.
Young people with stable favorable dental beliefs from
adolescence through adulthood have better clinical
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status and better self-rated oral health than those with
less stable beliefs [13]. Patients with AI did not express
negative attitudes towards dental treatment, either be-
fore or after crown therapy. Both patients with AI and
controls scored lower than a comparable group of Swed-
ish patients [30]. It is well known that patients with
MIH have tooth sensitivity problems and undergo many
dental treatments; although dental fear decreases over
time, the most negative attitudes toward dental treat-
ment occurred in this group [49]. Of the concerns that
they reported, lack of control and the need to be listened
to when reporting pain were highly ranked. Before treat-
ment, the severe AI group scored the item “I am con-
cerned that the dentist is not really looking out for my
best interests” as their top concern. After therapy this
item fell to rank 12 of 28 items.
A limitation of the current study was the dropouts in
the CLP and MIH groups due to patients not returning
the questionnaires. Another limitation was the advice to
the PDS clinics not to make composite resin restorations
before expected crown therapy in patients with AI. Limi-
tations related to questionnaires include that the ques-
tions are fixed and thus may not capture the children’s
own experiences of their disease. A qualitative approach
could possibly increase our understanding of the experi-
ences of having AI and receiving crown therapy early in
life. Strengths of this study include that it studied OHR-
QoL after treatment and that it estimated the clinically
meaningful effect.
Conclusion
In conclusion, we found that patients with AI rated their
OHRQoL significantly lower than healthy controls.
OHRQoL improved significantly in these patients after
crown therapy. Furthermore, the treatment effect was
clinically significant. Extensive dental therapy did not in-
crease dental fear or negative attitudes towards
dentistry.
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